News | Field Medical, Inc.

top of page

News

Field Medical Closes Oversubscribed $35 Million Series B to Advance Development of FieldForce™ Pulsed Field Ablation Platform

Field Medical Closes Oversubscribed $35 Million Series B to Advance Development of FieldForce™ Pulsed Field Ablation Platform

Field Medical Closes Oversubscribed $35 Million Series B to Advance Development of FieldForce™ Pulsed Field Ablation Platform

Field Medical Announces First-In-Human Data for Focal PFA in Scar-Related VT at Heart Rhythm 2025

Field Medical Announces First-In-Human Data for Focal PFA in Scar-Related VT at Heart Rhythm 2025

Field Medical Announces First-In-Human Data for Focal PFA in Scar-Related VT at Heart Rhythm 2025

Field Medical Closes $40 Million Series A Financing to Redefine Pulsed Field Ablation for Ventricular Tachycardia

Field Medical Closes $40 Million Series A Financing to Redefine Pulsed Field Ablation for Ventricular Tachycardia

Field Medical Closes $40 Million Series A Financing to Redefine Pulsed Field Ablation for Ventricular Tachycardia

Field Medical's FieldForce™ Ablation System Earns FDA TAP Pilot Acceptance and Breakthrough Device Designation for the Treatment of Ventricular Tachycardia.

Field Medical's FieldForce™ Ablation System Earns FDA TAP Pilot Acceptance and Breakthrough Device Designation for the Treatment of Ventricular Tachycardia.

Field Medical's FieldForce™ Ablation System Earns FDA TAP Pilot Acceptance and Breakthrough Device Designation for the Treatment of Ventricular Tachycardia.

LSI Europe '24 Presentation

LSI Europe '24 Presentation

LSI Europe '24 Presentation

Field Medical Announces First-in-Human Trials for Groundbreaking FieldForce™ Ventricular Pulsed Field Ablation Technology

Field Medical Announces First-in-Human Trials for Groundbreaking FieldForce™ Ventricular Pulsed Field Ablation Technology

Field Medical Announces First-in-Human Trials for Groundbreaking FieldForce™ Ventricular Pulsed Field Ablation Technology

Media Inquiries Welcome

media@fieldmedicalinc.com

+1 (980) 412-2298

Download the media kit

Connect with us on social media to keep informed on our progress.

Follow Us

bottom of page